Management of Multiple Myeloma with Bortezomib: Experts Review the Data and Debate the Issues

Publisher： Karger

E-ISSN： 1423-0232|70|6|474-482

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.6, 2007-02, pp. : 474-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib-Induced Rhabdomyolysis in Multiple Myeloma

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

The effects of bortezomib on bone disease in patients with multiple myeloma

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-Angiogenic Effect of Bortezomib in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 170-173

Karger

Access to resources Recommend Favorite

Severe Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma: A Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 128, Iss. 4, 2012-09 ,pp. : 244-247

Karger

Access to resources Recommend Favorite

A Systematic Review on the Use of Bortezomib in Multiple Myeloma Patients with Renal Impairment: What Is the Published Evidence?

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 163-168

Karger

Access to resources Recommend Favorite